Bracco, a global leader in diagnostic imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Mason Frazier, M.D., associate professor in the University of Alabama at Birmingham’s Marnix E. Heersink School of Medicine’s Department of Radiology, says contrast imaging is important part of ...
To obtain optical molecular images that reflect changes in biomarker expression requires the ability to deliver contrast agents to cells and tissues of interest, as well as the ability to wash away ...
Breast cancer remains one of the most prevalent cancers worldwide, accounting for 11.7 per cent of all cancer cases. In India, it is a leading cause of cancer-related deaths among […] ...
Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products “The ...
Problem: Recently, the Centers for Disease Control and Prevention (CDC) reiterated its position calling for medications labeled as "single dose" or "single use" to be ...
(RTTNews) - GE Healthcare said Monday that the U.S. Food and Drug Administration approved Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio ...
Contrast-enhanced mammography is a new imaging test that uses an IV contrast injection to help doctors detect breast cancer earlier in women with dense breasts. Why Elon Musk says saving for ...
CHALFONT ST GILES, England--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results